Cancer immune evasion through loss of MHC class I antigen presentation

K Dhatchinamoorthy, JD Colbert, KL Rock - Frontiers in immunology, 2021 - frontiersin.org
Major histocompatibility class I (MHC I) molecules bind peptides derived from a cell's
expressed genes and then transport and display this antigenic information on the cell …

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response

M von Locquenghien, C Rozalén… - The Journal of …, 2021 - Am Soc Clin Investig
Interferons (IFNs) are pleiotropic cytokines critical for regulation of epithelial cell functions
and for immune system regulation. In cancer, IFNs contribute to tumor-intrinsic and-extrinsic …

MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway

W Yang, Y Li, R Gao, Z Xiu, T Sun - Oncogene, 2020 - nature.com
Glioma stem cells (GSCs) decrease T cells cognition and evade systemic
immunosurveillance via downregulations or defects of major histocompatibility complex …

Spotlight on TAP and its vital role in antigen presentation and cross-presentation

I Mantel, BA Sadiq, JM Blander - Molecular immunology, 2022 - Elsevier
In the late 1980s and early 1990s, the hunt for a transporter molecule ostensibly responsible
for the translocation of peptides across the endoplasmic reticulum (ER) membrane yielded …

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer

RL Ferris, TL Whiteside, S Ferrone - Clinical Cancer Research, 2006 - AACR
Recent revival of interest in the role of immune surveillance in the pathogenesis and control
of malignant diseases has focused attention on escape mechanisms used by tumor cells to …

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

ANH Khan, CJ Gregorie, TB Tomasi - Cancer Immunology …, 2008 - Springer
Histone deacetylase inhibitors (HDACi), including trichostatin A (TSA) and valproic acid, can
alter the acetylation of histones in chromatin and enhance gene transcription. Previously we …

Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors

AF Setiadi, K Omilusik, MD David, RP Seipp… - Cancer research, 2008 - AACR
Histone deacetylase inhibitors (HDACi) have been hailed as a powerful new class of
anticancer drugs. The HDACi, trichostatin A (TSA), is thought to interfere with epigenetic …

TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer

A Ling, A Löfgren-Burström, P Larsson, X Li… - …, 2017 - Taylor & Francis
The anti-tumor immune response has been shown to be of great prognostic importance in
colorectal cancer (CRC) and so has the tumors ability for immune evasion. Our aim of this …

MHC/HLA class I loss in cancer cells

F Garrido, F Garrido - MHC class-I loss and cancer immune escape, 2019 - Springer
In this chapter I describe Tumour Immune Escape mechanisms associated with MHC/HLA
class I loss in human and experimental tumours. Different altered HLA class-I phenotypes …

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

S Pesonen, I Diaconu, L Kangasniemi, T Ranki… - Cancer research, 2012 - AACR
The immunosuppressive environment of advanced tumors is a primary obstacle to the
efficacy of immunostimulatory and vaccine approaches. Here, we report an approach to arm …